Next-generation phenotyping using the Parkin example: Time to catch up with genetics

JAMA Neurology

Volumn 70, Issue 9, 2013, Pages 1186-1191

  Grünewald, Anne ^a   Kasten, Meike ^a   Ziegler, Andreas ^a   Klein, Christine ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN;

ALLELE; CLINICAL FEATURE; DEMENTIA; DISEASE DURATION; DYSTONIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; MUTANT; ONSET AGE; PARKIN GENE; PARKINSON DISEASE; PRIORITY JOURNAL; PUBLICATION; QUALITATIVE RESEARCH; QUALITY CONTROL; QUANTITATIVE STUDY; RARE DISEASE; REVIEW; SYSTEMATIC REVIEW;

EID: 84883818381     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.488     Document Type: Review

References (10)

1. Lücking CB, Dürr A, Bonifati V, et al French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl JMed. 2000;342(21):1560-1567. (Pubitemid 30340501)
2. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605-608. (Pubitemid 28207717)
3. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015-1022. (Pubitemid 36628805)
4. Lohmann E, Periquet M, Bonifati V, et al French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol. 2003;54(2):176-185.
5. Oliveira SA, Scott WK, Martin ER, et al. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol. 2003;53(5):624-629. (Pubitemid 36529436)
6. Sun M, Latourelle JC, Wooten GF, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol. 2006;63(6):826-832. (Pubitemid 43882289)
7. Foroud T, Uniacke SK, Liu L, et al Parkinson Study Group. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology. 2003;60(5):796-801. (Pubitemid 36297363)
8. Kasten M, Kertelge L, Brüggemann N, et al. Nonmotor symptoms in genetic Parkinson disease. Arch Neurol. 2010;67(6):670-676.
9. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(9263):1191-1194. (Pubitemid 32378696)
10. Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med. 2009;150(3):206-215.